Konstantinos Vasileiou

Assistant Professor

University of Patras

Greece

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Konstantinos Vasileiou is an Assistant Professor at the University of Patras, Greece. His research focuses on pharmacogenomics, particularly in areas related to its adoption in clinical practice, the role of pharmacy education in shaping career choices, and the evaluation of safety concerns surrounding vaccines. Dr. Vasileiou's recent publications include studies on the economic assessment of pharmacogenomic-guided treatments and the analysis of adverse events reported post-COVID-19 vaccination.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Collaborators (3)

Sophia Hatziantoniou

Assistant Professor

University of Patras School of Medicine

GREECE

View details

George Patrinos

Associate Professor

University of Patras

GREECE

View details

Xando Díaz-Villamarín

Visiting lecturer

Universidad de Granada

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Konstantinos Vasileiou

Research Interests

Contact this professor

About

Articles (10)

How Can We Boost the Pharmacogenomics Adoption Rate in Clinical Practice Around the World?

How Do Pharmacy Students Make Career Choices in Genomics? Gender and Other Key Determinants of Pharmacy Senior Students' Intentions to Pursue Postgraduate Training in Pharmacogenomics

Adverse events of acute nephrotoxicity reported to EudraVigilance and VAERS after COVID-19 vaccination

Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study

Pharmacy students’ attitudes and intentions of pursuing postgraduate studies and training in pharmacogenomics and personalised medicine

Anaphylactic Reactions to COVID-19 Vaccines: An Updated Assessment Based on Pharmacovigilance Data

Anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents: Analysis of data reported to EudraVigilance

Examining key factors impact on health science students’ intentions to adopt genetic and pharmacogenomics testing: a comparative path analysis in two different healthcare settings

Comparative assessment of myocarditis and pericarditis reporting rates related to mRNA COVID-19 vaccines in Europe and the United States

Adoption of Pharmacogenomic Testing: A Marketing Perspective

Collaborators (3)

Sophia Hatziantoniou

George Patrinos

Xando Díaz-Villamarín

Make your next move.